G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/573 (2006.01) C12Q 1/26 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2269432
The invention relates to a method for predicting the onset of, diagnosing, and/or prognosticating dementing diseases. The method comprises determining the concentration of heme oxygenase-1 (HO-1) and/or a nucleotide sequence encoding HO-1 in tissue obtained from a patient, and comparing said concentration with the corresponding concentration of HO-1 and/or an HO-1 encoding nucleotide sequence in corresponding tissue obtained from at least one control person. The tissue is suitably plasma, lymphocytes, cerebrospinal fluid or fibroblasts. The method is useful where the dementing disease is any of Alzheimer's Disease, Age-Associated Cognitive Decline, Progressive Supranuclear Palsy, Vascular (i.e. multi-infarct) Dementia, Lewy Body Dementia, Huntington's Disease, Down's syndrome, normal pressure hydrocephalus, corticobasal ganglionic degeneration, multisystem atrophy, head trauma, Creutzfeld-Jacob disease, viral encephalitis and hypothyroidism.
Chertkow Howard
Schipper Hyman M.
Chertkow Howard
Schipper Hyman M.
Smart & Biggar
The Sir Mortimer B. Davis - Jewish General Hospital
LandOfFree
Ho-1 as a diagnostic and prognostic test for dementing diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ho-1 as a diagnostic and prognostic test for dementing diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ho-1 as a diagnostic and prognostic test for dementing diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1620343